May 12, 2022 — Vivalink, a leading provider of digital healthcare solutions,
announced availability of the world’s first multi-vital blood pressure patch for remote patient
monitoring for use in commercial research and development. The advanced multimodal
continuous signal processing patch uses electrical signal-based technologies to capture ECG
trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device. The
device is FDA/NMPA cleared for ECG and heart rate, and CE cleared for ECG, heart rate and
respiratory rate. The blood pressure feature is integrated and available for research and
development. Weighing just 7.5 grams and the size of a small bandage, the reusable and
rechargeable wearable patch requires no additional components such as a wristband or wires in
order to capture blood pressure.
Designed for remote and ambulatory patient monitoring such as hypertension diagnosis and
management, the patch is wireless network enabled to automatically capture and send a
continuous stream of data to clinical applications in the cloud. In addition, the patch contains
on-board memory in order to capture data during network outages, and then automatically
synchronize the data once network connections are re-established.
Key benefits of the blood pressure feature include automated readings of systolic and diastolic
pressure. The water resistant patch can be worn inconspicuously throughout the day to capture
blood pressure and other key vitals in remote settings and during sleep. Validation of the blood
pressure capability was conducted in accordance with ISO 81060-2 standards over a range of
physiological profiles.
Development of the advanced blood pressure algorithm is enabled by the use of Vivalink’s
Biometrics Data Platform which is uniquely designed to provide uninterrupted streams of
real-world physiological data for AI development. Other advanced algorithms in
development using the Biometrics Data Platform include cardiac mechanics and
hemodynamics.
“We pride ourselves in continuous innovation,” said Jiang Li, CEO at Vivalink. “This milestone
further establishes Vivalink as a leader and innovator in the remote patient monitoring market.”
The multi-vital blood pressure patch is available now for commercial research and development.
For more information: https://www.vivalink.com/
September 16, 2025 
